AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
IMPROVEMENT IN IMMUNE FUNCTION DUE TO TREATMENT WITH INDINAVIR DESPITE SEVERE IMMUNE-DEFICIENCY
Authors: ROTHEN M BISSET LR JOLLERJEMELKA HI GROB P LUTHY R OPRAVIL M
Citation: M. Rothen et al., IMPROVEMENT IN IMMUNE FUNCTION DUE TO TREATMENT WITH INDINAVIR DESPITE SEVERE IMMUNE-DEFICIENCY, Antiviral therapy, 3(3), 1998, pp. 159-167
LEVELS OF HIV-INFECTED PERIPHERAL-BLOOD CELLS REMAIN STABLE THROUGHOUT THE NATURAL-HISTORY OF HIV-1 INFECTION
Authors: CONE RW GOWLAND P OPRAVIL M GROB P LEDERGERBER B
Citation: Rw. Cone et al., LEVELS OF HIV-INFECTED PERIPHERAL-BLOOD CELLS REMAIN STABLE THROUGHOUT THE NATURAL-HISTORY OF HIV-1 INFECTION, AIDS, 12(17), 1998, pp. 2253-2260
HIV-ASSOCIATED PRIMARY PULMONARY-HYPERTENSION - A CASE-CONTROL STUDY
Authors: OPRAVIL M PECHERE M SPEICH R JOLLERJEMELKA HI JENNI R RUSSI EW HIRSCHEL B LUTHY R BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: M. Opravil et al., HIV-ASSOCIATED PRIMARY PULMONARY-HYPERTENSION - A CASE-CONTROL STUDY, American journal of respiratory and critical care medicine, 155(3), 1997, pp. 990-995
CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT
Authors: STALDER N SUDRE P OLMARI M OPRAVIL M GABRIEL V SANSONETTI A VONOVERBECK J HERBORT CP HIRSCHEL B BATTEGAY M BURGISSER P JEANNEROD L EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: N. Stalder et al., CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT, Clinical infectious diseases, 24(4), 1997, pp. 620-624
IMPACT OF NEW ANTIRETROVIRAL COMBINATION THERAPIES IN HIV-INFECTED PATIENTS IN SWITZERLAND - PROSPECTIVE MULTICENTER STUDY
Authors: EGGER M HIRSCHEL B FRANCIOLI P SUDRE P WIRZ M FLEPP M RICKENBACH M MALINVERNI R VERNAZZA P BATTEGAY M BERNASCONI E BURGISSER P ERB P FIERZ W GROB P GRUNINGER U JEANNEROD L LEDERGERBER B LUTHY R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W PIFFARETTI GC RUTSCHMANN O ZANETTI G
Citation: M. Egger et al., IMPACT OF NEW ANTIRETROVIRAL COMBINATION THERAPIES IN HIV-INFECTED PATIENTS IN SWITZERLAND - PROSPECTIVE MULTICENTER STUDY, BMJ. British medical journal, 315(7117), 1997, pp. 1194-1199
ANTIMICROBIALS FOR ACUTE OTITIS-MEDIA - A REVIEW FROM THE INTERNATIONAL PRIMARY-CARE NETWORK
Authors: FROOM J CULPEPPER L JACOBS M DEMELKER RA GREEN LA VANBUCHEM L GROB P HEEREN T
Citation: J. Froom et al., ANTIMICROBIALS FOR ACUTE OTITIS-MEDIA - A REVIEW FROM THE INTERNATIONAL PRIMARY-CARE NETWORK, BMJ. British medical journal, 315(7100), 1997, pp. 98-102
DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE IN THE SWISS HIV COHORT STUDY - INCREASING INCIDENCE, UNCHANGED PROGNOSIS
Authors: LOW N PFLUGER D EGGER M BATTEGAY M BERNASCONI E BURGISSER P ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B JEANNEROD L LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W PIFFARETTI GC RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: N. Low et al., DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE IN THE SWISS HIV COHORT STUDY - INCREASING INCIDENCE, UNCHANGED PROGNOSIS, AIDS, 11(9), 1997, pp. 1165-1171
TOXICITY, EFFICACY, PLASMA DRUG CONCENTRATIONS AND PROTEASE MUTATIONSIN PATIENTS WITH ADVANCED HIV-INFECTION TREATED WITH RITONAVIR PLUS SAQUINAVIR
Authors: LORENZI P YERLY S ABDERRAKIM K FATHI M RUTSCHMANN OT VONOVERBECK J LEDUC D PERRIN L HIRSCHEL B BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: P. Lorenzi et al., TOXICITY, EFFICACY, PLASMA DRUG CONCENTRATIONS AND PROTEASE MUTATIONSIN PATIENTS WITH ADVANCED HIV-INFECTION TREATED WITH RITONAVIR PLUS SAQUINAVIR, AIDS, 11(12), 1997, pp. 95-99
COMBINED HORMONO CHEMOTHERAPY AS PRIMARY-TREATMENT FOR METASTATIC PROSTATE-CANCER - A RANDOMIZED, MULTICENTER STUDY OF ORCHIECTOMY ALONE VERSUS ORCHIECTOMY PLUS ESTRAMUSTINE PHOSPHATE/
Authors: JANKNEGT RA BOON TA VANDEBEEK C GROB P
Citation: Ra. Janknegt et al., COMBINED HORMONO CHEMOTHERAPY AS PRIMARY-TREATMENT FOR METASTATIC PROSTATE-CANCER - A RANDOMIZED, MULTICENTER STUDY OF ORCHIECTOMY ALONE VERSUS ORCHIECTOMY PLUS ESTRAMUSTINE PHOSPHATE/, Urology, 49(3), 1997, pp. 411-420
MUTATIONAL CHARACTERIZATION OF PROMOTER REGIONS RECOGNIZED BY THE SALMONELLA-DUBLIN VIRULENCE PLASMID REGULATORY PROTEIN SPVR
Authors: GROB P KAHN D GUINEY DG
Citation: P. Grob et al., MUTATIONAL CHARACTERIZATION OF PROMOTER REGIONS RECOGNIZED BY THE SALMONELLA-DUBLIN VIRULENCE PLASMID REGULATORY PROTEIN SPVR, Journal of bacteriology, 179(17), 1997, pp. 5398-5406
SAFER SEX BEHAVIOR AND ALCOHOL-CONSUMPTION
Authors: LAUCHLI S HEUSSER R TSCHOPP A GUTZWILLER F HORNUNG R TWISSELMANN W RUFLI T ERB P RUTTIMANN S GILLI L HIRZ W WILLI B MALINVERNI R VONOVERBECK J MATTER L DEWECK A SCHOEP M HIRSCHEL B PERRIN L DELESDERRIER JC FRANCIOLI P FREI PH CHAVE JP FLEURY F LUTHY R GROB P OPRAVIL M GABERELL H
Citation: S. Lauchli et al., SAFER SEX BEHAVIOR AND ALCOHOL-CONSUMPTION, Annals of epidemiology, 6(4), 1996, pp. 357-364
REASONS FOR FAILURE OF PREVENTION OF TOXOPLASMA-ENCEPHALITIS
Authors: VANDELDEN C GABRIEL V SUDRE P FLEPP M VONOVERBECK J HIRSCHEL B BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: C. Vandelden et al., REASONS FOR FAILURE OF PREVENTION OF TOXOPLASMA-ENCEPHALITIS, AIDS, 10(5), 1996, pp. 509-513
MULTICENTER STUDY OF SAFETY AND IMMUNOGENICITY OF HIV-1 RGP160 CANDIDATE VACCINE IN SEROPOSITIVE HIV-1 VOLUNTEERS
Authors: GOEBEL FD MANNHALTER JW EIBL MM BELSHE RB GROB P ERFLE V GRIFFITHS PD WAHREN B KROHN K KUNSCHAK M ENGL W
Citation: Fd. Goebel et al., MULTICENTER STUDY OF SAFETY AND IMMUNOGENICITY OF HIV-1 RGP160 CANDIDATE VACCINE IN SEROPOSITIVE HIV-1 VOLUNTEERS, AIDS, 10, 1996, pp. 64-64
INFREQUENT DETECTION OF LIPOARABINOMANNAN ANTIBODIES IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED MYCOBACTERIAL DISEASE
Authors: BOGGIAN K FIERZ W VERNAZZA PL BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: K. Boggian et al., INFREQUENT DETECTION OF LIPOARABINOMANNAN ANTIBODIES IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED MYCOBACTERIAL DISEASE, Journal of clinical microbiology, 34(7), 1996, pp. 1854-1855
PROGNOSTIC VALUE OF VIREMIA IN PATIENTS WITH LONG-STANDING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: GALETTOLACOUR A YERLY S PERNEGER TV BAUMBERGER C HIRSCHEL B PERRIN L BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: A. Galettolacour et al., PROGNOSTIC VALUE OF VIREMIA IN PATIENTS WITH LONG-STANDING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 173(6), 1996, pp. 1388-1393
IN-VITRO BINDING OF THE SALMONELLA-DUBLIN VIRULENCE PLASMID REGULATORY PROTEIN SPVR TO THE PROMOTER REGIONS OF SPVA AND SPVR
Authors: GROB P GUINEY DG
Citation: P. Grob et Dg. Guiney, IN-VITRO BINDING OF THE SALMONELLA-DUBLIN VIRULENCE PLASMID REGULATORY PROTEIN SPVR TO THE PROMOTER REGIONS OF SPVA AND SPVR, Journal of bacteriology, 178(7), 1996, pp. 1813-1820
INTRATHECAL AND SERUM INTERLEUKIN-6 AND THE ACUTE-PHASE RESPONSE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURIES
Authors: KOSSMANN T HANS VHJ IMHOF HG STOCKER R GROB P TRENTZ O MORGANTIKOSSMANN MC
Citation: T. Kossmann et al., INTRATHECAL AND SERUM INTERLEUKIN-6 AND THE ACUTE-PHASE RESPONSE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURIES, Shock, 4(5), 1995, pp. 311-317
THE EUROPEAN-PUBLIC-HEALTH-ASSOCIATION
Authors: GROB P
Citation: P. Grob, THE EUROPEAN-PUBLIC-HEALTH-ASSOCIATION, Vaccine, 13, 1995, pp. 11-11
INTRODUCTION TO EPIDEMIOLOGY AND RISK OF HEPATITIS-B
Authors: GROB P
Citation: P. Grob, INTRODUCTION TO EPIDEMIOLOGY AND RISK OF HEPATITIS-B, Vaccine, 13, 1995, pp. 14-15
EPIDEMIOLOGY AND RISK OF HEPATITIS-B - SESSION 1 - DISCUSSION
Authors: GUERIN N GROB P ROURE C KATTAMIS C GOUDEAU A SEPETJAN M",CAETANO,"PHILPOT R MEHEUS A PAPAEVANGELOU G KANE M CROVARI P BELL A KOHLER R ESTEBAN R
Citation: N. Guerin et al., EPIDEMIOLOGY AND RISK OF HEPATITIS-B - SESSION 1 - DISCUSSION, Vaccine, 13, 1995, pp. 37-39
THE INFLUENCE OF LEUKOCYTE FILTRATION DURING CARDIOPULMONARY BYPASS ON POSTOPERATIVE LUNG-FUNCTION - A CLINICAL-STUDY
Authors: MIHALJEVIC T TONZ M VONSEGESSER LK PASIC M GROB P FEHR J SEIFERT B TURINA M
Citation: T. Mihaljevic et al., THE INFLUENCE OF LEUKOCYTE FILTRATION DURING CARDIOPULMONARY BYPASS ON POSTOPERATIVE LUNG-FUNCTION - A CLINICAL-STUDY, Journal of thoracic and cardiovascular surgery, 109(6), 1995, pp. 1138-1145
NOLA REPRESSES NOD GENE-EXPRESSION IN BRADYRHIZOBIUM-JAPONICUM
Authors: DOCKENDORFF TC SANJUAN J GROB P STACEY G
Citation: Tc. Dockendorff et al., NOLA REPRESSES NOD GENE-EXPRESSION IN BRADYRHIZOBIUM-JAPONICUM, Molecular plant-microbe interactions, 7(5), 1994, pp. 596-602
NODW IS ESSENTIAL FOR FULL EXPRESSION OF THE COMMON NODULATION GENES IN BRADYRHIZOBIUM-JAPONICUM
Authors: SANJUAN J GROB P GOTTFERT M HENNECKE H STACEY G
Citation: J. Sanjuan et al., NODW IS ESSENTIAL FOR FULL EXPRESSION OF THE COMMON NODULATION GENES IN BRADYRHIZOBIUM-JAPONICUM, Molecular plant-microbe interactions, 7(3), 1994, pp. 364-369
CROSS-TALK BETWEEN THE 2-COMPONENT REGULATORY SYSTEMS NODVW AND NWSABOF BRADYRHIZOBIUM-JAPONICUM
Authors: GROB P HENNECKE H GOTTFERT M
Citation: P. Grob et al., CROSS-TALK BETWEEN THE 2-COMPONENT REGULATORY SYSTEMS NODVW AND NWSABOF BRADYRHIZOBIUM-JAPONICUM, FEMS microbiology letters, 120(3), 1994, pp. 349-353
A PHASE I IIA CLINICAL-STUDY WITH A CHIMERIC MOUSE-HUMAN MONOCLONAL-ANTIBODY TO THE V3 LOOP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120/
Authors: GUNTHARD HF GOWLAND PL SCHUPBACH J FUNG MSC BONI J LIEU RS CHANG NT GROB P GRAEPEL P BRAUN DG LUTHY R
Citation: Hf. Gunthard et al., A PHASE I IIA CLINICAL-STUDY WITH A CHIMERIC MOUSE-HUMAN MONOCLONAL-ANTIBODY TO THE V3 LOOP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120/, The Journal of infectious diseases, 170(6), 1994, pp. 1384-1393
Risultati: 1-25 | 26-27